Infections: Clinical Trials

46,523 trials for Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29028 completed, 7160 unknown, 3096 recruiting, 2685 terminated. 11337 Not applicable, 8008 Phase 2, 6128 Phase 3, 5953 Phase 1, 4113 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable11337Completed 6878, Unknown 1836, Recruiting 893, Terminated 517, Not yet recruiting 471, Withdrawn 327, Active not recruiting 300, Enrolling by invitation 80, Suspended 35
Phase 28008Completed 5020, Unknown 885, Terminated 804, Recruiting 447, Withdrawn 396, Active not recruiting 226, Not yet recruiting 182, Suspended 33, Enrolling by invitation 15
Phase 36128Completed 4139, Unknown 692, Terminated 487, Recruiting 285, Withdrawn 218, Active not recruiting 152, Not yet recruiting 123, Suspended 27, Enrolling by invitation 5
Phase 15953Completed 4290, Unknown 448, Terminated 411, Recruiting 297, Withdrawn 224, Active not recruiting 142, Not yet recruiting 115, Enrolling by invitation 15, Suspended 11
Phase 44113Completed 2515, Unknown 685, Terminated 322, Recruiting 223, Withdrawn 146, Not yet recruiting 114, Active not recruiting 79, Enrolling by invitation 18, Suspended 11
Early Phase 1349Completed 149, Unknown 75, Recruiting 36, Not yet recruiting 32, Terminated 20, Withdrawn 19, Active not recruiting 13, Suspended 3, Enrolling by invitation 2

Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
CYFENDUS - Anthrax
Not yet recruitingEmergent BioSolutions2502035-11-012025-12-08
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Assessment of Myocarditis After Replication-Deficient Smallpox Immunization
JYNNEOS - Myopericarditis, Small Pox
Not yet recruitingWomack Army Medical Center23502029-03-012023-12-14
Antibiotics for Kidney Transplant Recipients
Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care - Kidney Transplant, Urinary Tract Infection(UTI)
Phase 4Not yet recruitingUniversity of California, San Francisco502028-10-012026-09-11
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS)
Not applicableNot yet recruitingKeck School of Medicine of USC2502028-09-012025-10-22
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Bubble CPAP Team-Based Care Strategy Feasibility Trial
bCPAP team-based care strategy - Pneumonia in Children
Not applicableNot yet recruitingYale University952028-04-012026-06-02
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
Effects of Food Intake on Biomarker Activity in Normal Humans Taking Immulina
Immulina, Placebo - Viral Diseases
Phase 2Not yet recruitingUniversity of Mississippi Medical Center2502028-01-012026-10-23
OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren
Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria
Phase 3Not yet recruitingIndiana University15002028-01-012026-09-01
School-Based Bladder Health Intervention
Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms
Not applicableWithdrawnStanford University2028-01-012026-05-07
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
Brief Videos for HIV Stigma - HIV, Mental Health
Not applicableNot yet recruitingCity University of New York, School of Public Health39002028-01-012026-10-01
Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis
Vasopressors, Fluids - Septic Shock, Fluid Resuscitation
Not yet recruitingAustralian and New Zealand Intensive Care Research Centre78382027-11-012026-11-09
Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU
Extended beta-lactam antibiotics, Intermittent Beta-lactam antibiotics - Sepsis, Septic Shock
Not yet recruitingAssiut University902027-10-012026-09-01
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
SD-ART - Hiv
Not applicableNot yet recruitingYale University1392027-10-012026-08-31
Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence
Ultrasound performed bycardiologis for diagnosis of rheumatic heart disease - Rheumatic Heart Diseases, Scabies
Not applicableNot yet recruitingCentre Hospitalier Universitaire de la Réunion9002027-10-012026-10-29
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines
Not applicableNot yet recruitingUniversity of Florida12962027-09-152026-09-14
Permethrin-Treated Baby Wraps for Malaria Prevention in Refugee Settings
Factory-treated lesu, Soaked lesu, Untreated lesu - Malaria (Plasmodium Falciparum), Malaria Incidence
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill13502027-09-012026-10-29
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
• Sivelestat intravenous infusion, NaCl intravenous infusion - Septic Shock, Coagulopathy
Phase 2Not yet recruitingUniversity Hospital, Strasbourg, France1202027-08-012026-08-20
Against Chikungunya Virus and Neonatal Infection
plasma transfusion : PC-CHIK-V - Chikungunya Virus Infection, Neonatal
Not applicableRecruitingCentre Hospitalier Universitaire de la Réunion602027-08-012026-09-15

Showing 20 of 46523. Sign in to see all of them.

Narrower conditions

COVID-19 (7576)  ·  HIV Infections (4681)  ·  Acquired Immunodeficiency Syndrome (3038)  ·  Sepsis (2312)  ·  Influenza, Human (2168)  ·  Hepatitis C (1722)  ·  Pneumonia (1395)  ·  Tuberculosis (1147)  ·  Malaria (1139)  ·  Coronavirus Infections (1112)  ·  Shock, Septic (1066)  ·  Hepatitis B (1006)  ·  Burkitt Lymphoma (977)  ·  Hepatitis C, Chronic (907)

Broader conditions

Virus Diseases (25700)  ·  RNA Virus Infections (21240)  ·  Respiratory Tract Diseases (15348)  ·  Pathological Conditions, Signs and Symptoms (14158)  ·  Respiratory Tract Infections (13984)  ·  Pathologic Processes (12531)  ·  Communicable Diseases (11504)  ·  Lung Diseases (11401)  ·  Blood-Borne Infections (10385)  ·  Urogenital Diseases (10058)  ·  Immune System Diseases (8972)  ·  Pneumonia (8709)  ·  Genital Diseases (8529)  ·  Nidovirales Infections (8342)

Interventions

Ribavirin (702)  ·  Blood Specimen Collection (484)  ·  Standard of Care (449)  ·  Influenza Vaccines (446)  ·  peginterferon alfa-2a (425)  ·  Ritonavir (420)  ·  Saline Solution (397)  ·  Sodium Chloride (391)  ·  Tenofovir (388)  ·  Lamivudine (325)  ·  Zidovudine (322)  ·  Azithromycin (294)  ·  Cyclophosphamide (277)  ·  efavirenz (225)  ·  Surveys and Questionnaires (219)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1911)  ·  GlaxoSmithKline (1187)  ·  Merck Sharp & Dohme LLC (536)  ·  Pfizer (452)  ·  Assistance Publique - Hôpitaux de Paris (436)  ·  Sanofi Pasteur, a Sanofi Company (339)  ·  Assiut University (316)  ·  University of Oxford (293)  ·  University of California, San Francisco (291)  ·  Gilead Sciences (283)  ·  National Cancer Institute (NCI) (271)  ·  ViiV Healthcare (257)  ·  Hoffmann-La Roche (244)  ·  Bristol-Myers Squibb (220)  ·  University of North Carolina, Chapel Hill (212)

Countries

United States (14628)  ·  France (3430)  ·  China (3080)  ·  Canada (2133)  ·  United Kingdom (1982)  ·  Spain (1910)  ·  Germany (1848)  ·  Italy (1665)  ·  Brazil (1261)  ·  Turkey (Türkiye) (1151)  ·  Belgium (1081)  ·  Australia (1069)  ·  South Africa (1027)  ·  South Korea (918)  ·  Netherlands (902)

Results publications

PMID 34473343, PMID 41276263, PMID 35244208, PMID 31986264, PMID 35713300, PMID 41671463, PMID 32031570, PMID 26903338, PMID 32109013, PMID 32091533, PMID 32171076, PMID 34013969, PMID 36734509, PMID 37162745, PMID 41159585, PMID 33502773, PMID 37068952, PMID 37781954, PMID 37947276, PMID 38700045, PMID 39324693, PMID 39807668, PMID 36695483, PMID 30739368, PMID 32779730, PMID 34658014, PMID 37489818, PMID 37591523, PMID 35622074, PMID 37010196, PMID 40190112, PMID 40260835, PMID 25820067, PMID 30977945, PMID 32167524, PMID 32813276, PMID 40099800, PMID 30012435, PMID 30923816, PMID 32335895, PMID 33215698, PMID 34350582, PMID 28193518, PMID 29461687, PMID 31568620, PMID 32142651, PMID 32192578, PMID 32250385, PMID 33305842, PMID 33616229

NIH funding

2014 (138), 2023 (128), 2015 (125), 2019 (122), 2009 (106), 2016 (104), 2018 (98), 2008 (89), 2017 (86), 2025 (77), 2005 (39), P30CA033572 (29), P30CA015704 (28), 2004 (27), U01AI068636 (27)